Human Genome Epidemiology Literature Finder
Records 1 - 14 (of 14 Records) |
Query Trace: Lymphoma and CXCR4[original query] |
---|
CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma. Journal of clinical laboratory analysis 2009 23 (6): 387-93. de Oliveira Karen Brajão, Oda Julie Massayo Maeda, Voltarelli Julio Cesar, Nasser Thiago Franco, Ono Mario Augusto, Fujita Thiago Cezar, Matsuo Tiemi, Watanabe Maria Angelica Eha |
Polymorphism of CD44 influences the efficacy of CD34(+) cells mobilization in patients with hematological malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2014 Jul 20 (7): 986-91. Szmigielska-Kaplon Anna, Szemraj Janusz, Hamara Katarzyna, Robak Marta, Wolska Anna, Pluta Agnieszka, Czemerska Magdalena, Krawczynska Anna, Jamroziak Krzysztof, Szmigielska Katarzyna, Robak Tadeusz, Wierzbowska Agniesz |
CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group. Pediatric blood & cancer 2016 May . Matsuo Hidemasa, Nakamura Naomi, Tomizawa Daisuke, Saito Akiko Moriya, Kiyokawa Nobutaka, Horibe Keizo, Nishinaka-Arai Yoko, Tokumasu Mayu, Itoh Hiroshi, Kamikubo Yasuhiko, Nakayama Hideki, Kinoshita Akitoshi, Taga Takashi, Tawa Akio, Taki Tomohiko, Tanaka Shiro, Adachi Souic |
Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease. Annals of hematology 2017 Mar . Cao Xin-Xin, Meng Qi, Cai Hao, He Tian-Hua, Zhang Cong-Li, Su Wei, Sun Jian, Li Yue, Xu Wei, Zhou Dao-Bin, Li Ji |
Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. Blood 2017 1 129 (4): 473-483. Krysiak Kilannin, Gomez Felicia, White Brian S, Matlock Matthew, Miller Christopher A, Trani Lee, Fronick Catrina C, Fulton Robert S, Kreisel Friederike, Cashen Amanda F, Carson Kenneth R, Berrien-Elliott Melissa M, Bartlett Nancy L, Griffith Malachi, Griffith Obi L, Fehniger Todd |
Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's Macroglobulinemia. The New England journal of medicine 2018 6 378 (25): 2399-2410. Dimopoulos Meletios A, Tedeschi Alessandra, Trotman Judith, García-Sanz Ramón, Macdonald David, Leblond Veronique, Mahe Beatrice, Herbaux Charles, Tam Constantine, Orsucci Lorella, Palomba M Lia, Matous Jeffrey V, Shustik Chaim, Kastritis Efstathios, Treon Steven P, Li Jianling, Salman Zeena, Graef Thorsten, Buske Christian, |
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network. American journal of hematology 2019 Aug . Varettoni Marzia, Boveri Emanuela, Zibellini Silvia, Tedeschi Alessandra, Candido Chiara, Ferretti Virginia Valeria, Rizzo Ettore, Doni Elisa, Merli Michele, Farina Lucia, Goldaniga Maria, Gallì Anna, Rattotti Sara, Frustaci Anna Maria, Deodato Marina, Bandiera Laura, Isimbaldi Giuseppe, Uccella Silvia, Cabras Antonello Domenico, Gianelli Umberto, Baldini Luca, Paulli Marco, Arcaini Lu |
MYD88 and CXCR4 Mutation Profiling in Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinaemia. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2019 3 35 (1): 57-65. Vinarkar Sushant, Arora Neeraj, Chowdhury Sourav Sarma, Saha Kallol, Pal Biswajoy, Parihar Mayur, Radhakrishnan Vivek S, Chakrapani Anupam, Bhartia Shilpa, Bhave Saurabh, Chandy Mammen, Nair Reena, Mishra Deepak Kum |
Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia. Blood 2020 11 137 (20): 2800-2816. Klintman Jenny, Appleby Niamh, Stamatopoulos Basile, Ridout Katie, Eyre Toby A, Robbe Pauline, Pascua Laura Lopez, Knight Samantha J L, Dreau Helene, Cabes Maite, Popitsch Niko, Ehinger Mats, Martín-Subero Jose I, Campo Elías, Månsson Robert, Rossi Davide, Taylor Jenny C, Vavoulis Dimitrios V, Schuh An |
Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia. Neoplasia (New York, N.Y.) 2021 3 23 (4): 361-374. Wang Yingjun, Gali Vasantha Lakshmi, Xu-Monette Zijun Y, Sano Dahlia, Thomas Sheeba K, Weber Donna M, Zhu Feng, Fang Xiaosheng, Deng Manman, Zhang Mingzhi, Hagemeister Fredrick B, Li Yong, Orlowski Robert Z, Lee Hans Chulhee, Young Ken |
De Novo CD5-positive diffuse large B-cell lymphoma: A genomic profiling study and prognostic analysis of 46 patients. Annals of diagnostic pathology 2022 3 58 151886. Fan Yue, Binshen Ouyang, Zhang Zhihan, Yi Hongmei, Zhang Wenjing, Liu Qingxiao, Liu Yang, Dong Lei, Wang Chao |
Mutational Profile in 75 Patients With Anti-Myelin-Associated Glycoprotein Neuropathy: Clinical and Hematologic Therapy Response and Hints on New Therapeutic Targets. Neurology(R) neuroimmunology & neuroinflammation 2023 5 10 (4): . Francesca Castellani, Andrea Visentin, Erika Schirinzi, Alessandro Salvalaggio, Mario Cacciavillani, Cinzia Candiotto, Claudia Baratè, Alessandro Cellini, Roberta Bertorelle, Gabriele Siciliano, Livio Trentin, Chiara Bria |
Waldenström macroglobulinemia and non-IgM-type lymphoplasmacytic lymphoma are genetically similar. Acta haematologica 2023 3 . Awata-Shiraiwa Maaya, Yokohama Akihiko, Kanai Yukihiro, Gotoh Nanami, Kasamatsu Tetsuhiro, Handa Hiroshi, Saitoh Takayuki, Murakami Hirokazu, Hirato Junko, Ikota Hayato, Tsukamoto Norifu |
Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma. HemaSphere 2023 11 7 (11): e976. Madeleine R Berendsen, Diede A G van Bladel, Eva Hesius, Cristina Berganza Irusquieta, Jos Rijntjes, Annemiek B van Spriel, Ellen van der Spek, Johannes F M Pruijt, Leonie I Kroeze, Konnie M Hebeda, Sandra Croockewit, Wendy B C Stevens, J Han J M van Krieken, Patricia J T A Groenen, Michiel van den Brand, Blanca Scheij |
- Page last reviewed:Feb 1, 2024
- Content source: